Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities
This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe.
Nemera today announced that they have entered into an agreement to...
Safe’n’Spray: Winner at CPhI Festival of Pharma
Nemera’s concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October...
New director takes the helm
Teesside University’s £22m National Horizons Centre opened last September with two objectives, to drive research into bioprocessing and to plug the yawning skills gap.
Co-author...
Priority response plan (prp) for bio-decontamination of a biopharmaceutical production facility
Multinational Biopharmaceutical Company, Singapore - case study
EXECUTIVE SUMMARY
A multinational biopharmaceutical company in Asia, was looking to introduce a rigorous plan to ensure high-level bio-decontamination...